date,title,source
Oct-22-18,Strongbridge Biopharma plc Presents Detailed Initial Results from Pivotal Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 18th Annual Congress of the European NeuroEndocrine Association,GlobeNewswire
Oct-31-18,$181.7M deal: Strongbridge to sell rights to hormone drug to Novo Nordisk,American City Business Journals
Oct-31-18,"Strongbridge Biopharma (SBBP) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Oct-31-18,Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Oct-31-18,Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN (macimorelin),GlobeNewswire
Nov-01-18,Edited Transcript of SBBP earnings conference call or presentation 31-Oct-18 1:15pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Todays Research Reports on Stocks to Watch: Strongbridge Biopharma and Clovis Oncology,ACCESSWIRE
Nov-05-18,Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference,GlobeNewswire
Nov-09-18,Edited Transcript of SBBP earnings conference call or presentation 31-Oct-18 1:15pm GMT,Thomson Reuters StreetEvents
Nov-12-18,Edited Transcript of SBBP earnings conference call or presentation 31-Oct-18 1:15pm GMT,Thomson Reuters StreetEvents
Nov-13-18,Edited Transcript of SBBP earnings conference call or presentation 31-Oct-18 1:15pm GMT,Thomson Reuters StreetEvents
Nov-20-18,"Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV, and Ketoconazole on Human Cortisol Production",GlobeNewswire
Nov-27-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Dillard's, Biohaven Pharmaceutical Holding, HTG Molecular Diagnostics, Strongbridge Biopharma, Myriad Genetics, and Beazer Homes  New Research Emphasizes Economic Growth",GlobeNewswire
Dec-18-18,Do Hedge Funds Love Strongbridge Biopharma plc (SBBP)?,Insider Monkey
Dec-19-18,Strongbridge completes $181.7M sale of hormone drug to Novo Nordisk,American City Business Journals
Dec-19-18,Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN (macimorelin) in the United States and Canada,GlobeNewswire
Jan-23-19,These 2 Biotech Stocks Seem Significantly Undervalued,TheStreet.com
Jan-31-19,What Kind Of Investor Owns Most Of Strongbridge Biopharma plc (NASDAQ:SBBP)?,Simply Wall St.
Feb-19-19,"Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019",GlobeNewswire
Feb-22-19,Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders,GlobeNewswire
Feb-26-19,Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-26-19,Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2018 Financial Results,GlobeNewswire
Feb-27-19,Strongbridge Biopharma plc to Present at the Cowen and Company 39th Annual Healthcare Conference and the Oppenheimer 29th Annual Healthcare Conference,GlobeNewswire
Mar-04-19,What's in the Cards for Aeterna (AEZS) This Earnings Season?,Zacks
Mar-04-19,Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 Annual Meeting of the Endocrine Society (ENDO),GlobeNewswire
Mar-07-19,Edited Transcript of SBBP earnings conference call or presentation 26-Feb-19 1:30pm GMT,Thomson Reuters StreetEvents
Mar-08-19,Strongbridge Biopharma plc Announces New Employment Inducement Awards,GlobeNewswire
Mar-11-19,Is Strongbridge Biopharma plc (NASDAQ:SBBP) Potentially Underrated?,Simply Wall St.
Mar-11-19,Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Potential Treatment of Endogenous Cushings Syndrome,GlobeNewswire
Mar-25-19,Strongbridge Biopharma plc Announces Presentation of New Data Analyses from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Potential Treatment of Endogenous Cushings Syndrome,GlobeNewswire
Apr-15-19,Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 American Association of Clinical Endocrinologists (AACE) Annual Scientific and Clinical Congress,GlobeNewswire
Apr-18-19,Does Strongbridge Biopharma plc's (NASDAQ:SBBP) CEO Pay Compare Well With Peers?,Simply Wall St.
Apr-25-19,Strongbridge Biopharma plc Announces Presentation of New Secondary Endpoint Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 American Association of Clinical Endocrinologists Annual Scientific and Clinical Congress,GlobeNewswire
Apr-26-19,"News Surrounds 3 Small Biotechs, With a Merger Claiming One",TheStreet.com
Apr-26-19,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",Benzinga
May-01-19,"Strongbridge Biopharma (SBBP) Reports Q1 Loss, Lags Revenue Estimates",Zacks
May-01-19,Strongbridge Biopharma plc (SBBP) Q1 2019 Earnings Call Transcript,Motley Fool
May-01-19,Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update,GlobeNewswire
